Canada Markets closed

BioSyent Inc. (RX.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
7.80+0.01 (+0.13%)
At close: 03:57PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.94
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 310.00
52 Week Low 36.76
50-Day Moving Average 38.37
200-Day Moving Average 38.14

Share Statistics

Avg Vol (3 month) 33.43k
Avg Vol (10 day) 37.2k
Shares Outstanding 512.58M
Implied Shares Outstanding 6N/A
Float 89.81M
% Held by Insiders 139.42%
% Held by Institutions 11.28%
Shares Short (Apr 28, 2022) 4729
Short Ratio (Apr 28, 2022) 40.27
Short % of Float (Apr 28, 2022) 4N/A
Short % of Shares Outstanding (Apr 28, 2022) 40.01%
Shares Short (prior month Mar 30, 2022) 41.27k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Dec 30, 2021


Profit Margin 21.95%
Operating Margin (ttm)28.59%

Management Effectiveness

Return on Assets (ttm)14.46%
Return on Equity (ttm)21.53%

Income Statement

Revenue (ttm)28.62M
Revenue Per Share (ttm)2.26
Quarterly Revenue Growth (yoy)26.10%
Gross Profit (ttm)22.64M
Net Income Avi to Common (ttm)6.28M
Diluted EPS (ttm)0.39
Quarterly Earnings Growth (yoy)182.10%

Balance Sheet

Total Cash (mrq)28.21M
Total Cash Per Share (mrq)2.27
Total Debt (mrq)1.56M
Total Debt/Equity (mrq)4.93
Current Ratio (mrq)8.24
Book Value Per Share (mrq)2.40

Cash Flow Statement

Operating Cash Flow (ttm)4.67M
Levered Free Cash Flow (ttm)3.15M